Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
PUT
Direxion Daily FTSE China Bull 3X ETF
YINN
$653M
| $7.37M | ﹤0.01% |
74,710
+54,730
| +274% | +$4.52M |
|
|
TBCH
3027
CALL
Turtle Beach Corp
TBCH
$228M
| $7.36M | ﹤0.01% |
601,500
+156,700
| +35% | +$2.67M |
|
3028
Deluxe
DLX
$1.1B
| $7.35M | ﹤0.01% |
339,012
+173,249
| +105% | +$4.41M |
|
|
BPMC
3029
CALL
DELISTED
Blueprint Medicines
BPMC
| $7.34M | ﹤0.01% |
145,400
+137,200
| +1,673% | +$8.04M |
|
|
AONC
3030
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
| $7.34M | ﹤0.01% |
750,631
+609
| +0.1% | +$5.96K |
|
3031
PUT
Freshpet
FRPT
$3.5B
| $7.32M | ﹤0.01% |
141,100
+116,000
| +462% | +$8.95M |
|
3032
iShares TIPS Bond ETF
TIP
$14.7B
| $7.32M | ﹤0.01% |
64,249
-27,605
| -30% | -$3.27M |
|
3033
MaxLinear
MXL
$7.69B
| $7.31M | ﹤0.01% |
215,017
+206,676
| +2,478% | +$8.66M |
|
3034
CALL
United Therapeutics
UTHR
$21.4B
| $7.3M | ﹤0.01% |
31,000
-49,500
| -61% | -$10.1M |
|
3035
TG Therapeutics
TGTX
$7.46B
| $7.3M | ﹤0.01% |
1,717,444
+640,516
| +59% | +$4M |
|
|
COOP
3036
CALL
DELISTED
Mr. Cooper
COOP
| $7.3M | ﹤0.01% |
198,600
+13,300
| +7% | +$563K |
|
3037
KeyCorp
KEY
$25B
| $7.29M | ﹤0.01% |
423,349
-2,244,104
| -84% | -$43.4M |
|
3038
Northrop Grumman
NOC
$83.2B
| $7.29M | ﹤0.01% |
15,238
+3,920
| +35% | +$1.8M |
|
3039
Boise Cascade
BCC
$2.9B
| $7.29M | ﹤0.01% |
122,538
-4,085
| -3% | -$301K |
|
3040
PUT
Sprout Social
SPT
$599M
| $7.29M | ﹤0.01% |
125,500
-33,900
| -21% | -$1.97M |
|
3041
CoreCivic
CXW
$3.25B
| $7.29M | ﹤0.01% |
655,734
+161,748
| +33% | +$1.95M |
|
3042
PUT
Mid-America Apartment Communities
MAA
$15.5B
| $7.28M | ﹤0.01% |
41,700
+800
| +2% | +$149K |
|
|
FHLT
3043
DELISTED
Future Health ESG Corp. Common stock
FHLT
| $7.28M | ﹤0.01% |
735,712
+69,273
| +10% | +$686K |
|
|
ANSS
3044
CALL
DELISTED
Ansys
ANSS
| $7.27M | ﹤0.01% |
30,400
-4,400
| -13% | -$1.16M |
|
|
SHAC
3045
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $7.27M | ﹤0.01% |
742,889
-502,455
| -40% | -$4.93M |
|
3046
CALL
Lemonade
LMND
$4.07B
| $7.26M | ﹤0.01% |
397,700
-32,500
| -8% | -$685K |
|
3047
PUT
Vanguard Dividend Appreciation ETF
VIG
$114B
| $7.26M | ﹤0.01% |
50,600
+24,400
| +93% | +$3.71M |
|
3048
CALL
Pan American Silver
PAAS
$19.7B
| $7.26M | ﹤0.01% |
369,000
-210,500
| -36% | -$5.05M |
|
3049
Kforce
KFRC
$1.04B
| $7.25M | ﹤0.01% |
118,133
+50,549
| +75% | +$3.45M |
|
3050
PUT
Range Resources
RRC
$9.42B
| $7.24M | ﹤0.01% |
292,500
+96,600
| +49% | +$2.96M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.